September 14, 2012
The Food and Drug Administration has approved a new once-a-day pill for HIV. The drug is as effective as other drugs already on the market. Some experts are concerned the high cost will make it unaffordable for patients.
Topics: Social Issues, Health Medical Pharma, Pharmaceutical sciences, Pharmacology, Health, Medicine, Emtricitabine/tenofovir/efavirenz, HIV/AIDS in China, Therapeutics , Clinical pharmacology, Prescription Drug User Fee Act, HIV, HIV/AIDS, United States Public Health Service, Pharmacy, Food and Drug Administration